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ABSTRACT
Background Appendectomy is considered the gold
standard treatment for acute appendicitis. Recently the
need for surgery has been challenged in both adults and
children. In children there is growing clinician, patient
and parental interest in non-operative treatment of acute
appendicitis with antibiotics as opposed to surgery. To
date no multicentre randomised controlled trials that
are appropriately powered to determine efficacy of nonoperative treatment (antibiotics) for acute appendicitis
in children compared with surgery (appendectomy) have
been performed.
Methods Multicentre, international, randomised controlled
trial with a non-inferiority design. Children (age 5–16
years) with a clinical and/or radiological diagnosis of acute
uncomplicated appendicitis will be randomised (1:1 ratio) to
receive either laparoscopic appendectomy or treatment with
intravenous (minimum 12 hours) followed by oral antibiotics
(total course 10 days). Allocation to groups will be stratified
by gender, duration of symptoms (> or <48 hours) and centre.
Children in both treatment groups will follow a standardised
treatment pathway. Primary outcome is treatment failure
defined as additional intervention related to appendicitis
requiring general anaesthesia within 1 year of randomisation
(including recurrent appendicitis) or negative appendectomy.
Important secondary outcomes will be reported and a costeffectiveness analysis will be performed. The primary outcome
will be analysed on a non-inferiority basis using a 20% noninferiority margin. Planned sample size is 978 children.
Discussion The APPY trial will be the first multicentre
randomised trial comparing non-operative treatment
with appendectomy for acute uncomplicated
appendicitis in children. The results of this trial have the
potential to revolutionise the treatment of this common
gastrointestinal emergency. The randomised design
will limit the effect of bias on outcomes seen in other
studies.
Trial registration number clinicaltrials.gov:
NCT02687464. Registered on Jan 13th 2016.

What is already known on this topic?
►► Appendectomy has been the mainstay of treatment

of acute appendicitis for over 100 years.
►► Recently the need for surgery for uncomplicated

acute appendicitis has been challenged and current
data suggest the majority of children can be treated
with a non-operative treatment pathway instead of
surgery.
►► The comparative safety and efficacy of non-operative
treatment compared with surgery have not yet been
determined.

What this study hopes to add?
►► This study will determine the relative efficacy of non-

operative treatment compared with appendectomy.
►► The randomised study design will help to eliminate

bias between treatment groups that may exist in
other study types.
►► The pragmatic trial design will help to ensure
generalisability of trial results.

BACKGROUND
Acute appendicitis is the most common
surgical emergency in children.1 The lifetime
risk of developing appendicitis is 7%–8%,
with a peak incidence in the teenage years.
The associated financial burden of treating
appendicitis is very large.
For over 100 years, surgical removal of
the appendix has been deemed necessary to effectively treat acute appendicitis.
Appendectomy remains the cornerstone of
treatment for acute appendicitis, with the
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►► Large well-designed randomised controlled trial comparing non-

operative management with surgery for children with acute
uncomplicated appendicitis.
►► Pragmatic diagnostic and treatment protocols.
►► An international multicentre study.
►► Non-blinded.
►► May include children without appendicitis since the diagnosis
reflects current practice of clinical +/- radiological assessment.

exception of a phlegmon or appendix mass.2 However, in
recent years this surgical dogma has been challenged and
there is a growing literature to suggest that antibiotics
without surgery may be an effective treatment for acute
appendicitis in adults and more recently in children.
This non-operative management of acute appendicitis
remains controversial and unproven due to the lack of
well designed large prospective randomised controlled
trials (RCTs).3
Although appendectomy is generally a simple procedure, it requires general anaesthesia and is an abdominal
operation with inherent risks and potential complications. Complications related to surgery or anaesthesia
occur in over 10% of children within 30 days of appendectomy.4 Although a non-operative approach may avoid
these risks and reduce the complication rate, this would
not be a viable alternative to surgery unless it is effective at curing acute appendicitis. Another important
consideration is that some patients with a clinical and/or
radiological diagnosis of acute appendicitis may not actually have acute appendicitis. Even with current imaging
methods, 6.3% of children in Canada and 4.3% in the

Table 1 Existing literature relating to non-operative treatment of acute uncomplicated appendicitis in children
Study

Country of
origin

Year of
publication Study design

Kaneko et al33
Abes et al34

Japan
Turkey

2004
2007

Prospective cohort
Retrospective cohort

22
16

No
No

Armstrong et al35

Canada

2014

Non-randomised retrospective
cohort

12

Yes

Koike et al36

Japan

2014

Retrospective cohort

130

No

Gorter et al27

Holland

2015

Non-randomised prospective
cohort

25

Yes

Hartwich et al37

USA

2015

Prospective parent preferencebased feasibility trial

24

Yes

Minneci et al32

USA

2015

Prospective parent preferencebased trial

37

Yes

Svensson et al16

Sweden

2015

Pilot RCT

24

Yes

Steiner et al

Israel

2015

45

No

Tanaka et al39

Japan

2015

Non-randomised prospective
cohort
Non-randomised prospective
cohort

78

Yes

38

No. of children receiving Comparative
non-operative treatment study*

*Included a comparison group who underwent appendectomy.
RCT,randomised controlled trial.
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USA undergoing appendectomy are subsequently found
to have a normal appendix.5 Consequently, this could
be considered to be an unnecessary operation. Surgery
causes trauma, physiological stress and physical scarring
in the child and psychological stress and distress in their
parents. A non-operative approach might reduce these.
There may be social and economic benefits to the child
and family arising from reduced time away from normal
daily activities including schooling and parental time off
work, and there may be benefits for the healthcare system
and society. However, there is the issue of recurrent
appendicitis. Following successful non-operative treatment, children would be left with an appendix and be at
risk of recurrent appendicitis. The benefits of successful
non-operative treatment would only be realised if the
rate of recurrent appendicitis is low. If a high proportion
of children will develop a recurrence, then there is likely
to be less benefit from an initial non-operative approach.
The existing literature relating to the efficacy of non-operative treatment of acute appendicitis is predominantly
from adult patients. Several trials and systematic reviews
have been reported.3 6–12 In a 2012 meta-analysis Mason
et al concluded that while there were benefits to non-operative treatment including fewer complications, better
pain control and shorter sick leave, the combined failure
and recurrence rates in non-operative patients made this
approach less effective overall.11 However, in the same
year Varadhan et al concluded from their meta-analysis
that ‘antibiotics can be used safely as primary treatment
in patients presenting with acute uncomplicated appendicitis’ since 63% of patients respond to non-operative
treatment.12

Strengths and limitations

Open Access
Inclusion criteria

METHODS/DESIGN

Interventions
Patients will be allocated to non-operative antibiotic treatment or appendectomy. Figure 1 illustrates patient flow
through the two treatment pathways during the acute
admission following randomisation.

Trial design
The APPY trial has been designed as a pragmatic, parallel-group, unmasked, non-inferiority, multicentre,
international, RCT. The protocol has been developed in
accordance with the SPIRIT (Standard Protocol Items:
Recommendations for Interventional Trials) guideline17
and the trial will be conducted and reported according to
the CONSORT statement.18 19 The trial is registered with
clinicaltrials.gov: NCT02687464.
Participants
Children (5–16 years of age) with suspected acute
uncomplicated appendicitis will be enrolled. All children
with suspected acute non-perforated appendicitis will be
assessed by the on-call surgeon who will determine eligibility for the study. This will be based on a clinical and/or
ultrasound (US) or CT diagnosis of acute non-perforated
appendicitis. The parent(s) and child will be informed of
the trial and invited to participate.
Hall NJ, et al. BMJ Paediatrics Open 2017;1:e000028. doi:10.1136/bmjpo-2017-000028

►► children (age 5–16 years)
►► clinical and/or radiological diagnosis (US and/or
CT scan) of acute non-perforated appendicitis
►► written informed parental consent in accordance
with local regulations and institutional policy
►► written informed child assent in accordance with
local regulations and institutional policy
Exclusion criteria
►► suspicion of perforated appendicitis
►► presentation with an appendix mass or phlegmon
(on physical examination and/or imaging)
►► non-operative management (two or more doses
of intravenous antibiotic) initiated at an outside
institution
►► previous episode of appendicitis or appendix mass/
phlegmon treated non-operatively
►► current treatment for malignancy
►► positive pregnancy test
►► diagnosis of cystic fibrosis
Randomisation
After signed informed consent, a standardised data
set will be collected from all participants at all participating institutions. Patients enrolled in the study will be
randomised to groups (1:1 ratio) using an online stratified randomisation tool, allowing instant assignment to
treatment group 24 hours per day with concealment of
allocation. Allocation to groups will be stratified taking
into account factors that may affect outcome of treatment:
(1) Gender: Male; Female; (2) Duration of symptoms
<48 hours; >48 hours; and (3) Centre. Due to the nature
of the interventions blinding will not be possible, and as
imaging is not an inclusion criterion, it is not possible to
stratify by presence/absence of faecolith.

Non-operative treatment group
Participants allocated to non-operative treatment will be
treated according to a treatment pathway standardised
across all centres comprising intravenous fluid treatment, a minimum of 12 hours of intravenous antibiotics,
a minimum period of 12 hours taking clear fluid only and
regular clinical review. This review is conducted to detect
symptoms and signs of clinical deterioration including,
but not limited to, increased fever, increased tachycardia,
and increased pain or tenderness. An additional formal
review will be performed the following day and children
who are stable or clinically improving will continue with
non-operative treatment.
Children in whom non-operative treatment is successful
will receive a minimum of 12 hours intravenous antibiotics
3
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In children, the literature is limited (table 1). While
antibiotic therapy appears successful in the majority of
children with acute uncomplicated appendicitis, no large
randomised study of acute appendicitis in children has
yet been performed (although there have been RCTs of
antibiotic treatment of perforated appendicitis in children13 14). A recent systematic review and meta-analysis of
the efficacy of non-operative treatment of acute uncomplicated appendicitis in children demonstrated that
non-operative treatment is effective as initial treatment
in 97% of cases.15
In preparation for this multicentre RCT, some of our
group have performed a pilot RCT at one of the participating centres (Karolinska Institutet, Stockholm).16 We
have successfully demonstrated feasibility of recruitment
to an RCT and demonstrated safety of non-operative
treatment of children with acute appendicitis. Furthermore, we have generated pilot data on which our current
study is now based. In the pilot RCT all 26 children
randomised to appendectomy had histopathologically
confirmed acute appendicitis and recovered without
significant complications. Only 2 of 24 children in the
antibiotic group required appendectomy for histologically proven acute appendicitis within 1 year. Of eligible
participants, the recruitment rate was 40%, the dropout
rate following treatment allocation was 2% (1 patient)
and no patient was lost to follow-up by 1 year.
Based on these observations, and in response to parents
who are now asking whether their child with acute appendicitis really needs an operation, we will perform a large,
prospective, multicentre, RCT comparing appendectomy
with non-operative treatment in children with acute
appendicitis. Our principal research question is: Can
children with acute uncomplicated (non-perforated)
appendicitis be treated without appendectomy?

Open Access

and then be switched to oral antibiotics once they have
shown clinical improvement. They will be discharged
home once they meet a standardised set of criteria to
be used in all centres: vital signs (including temperature) within normal limits, tolerating a light diet orally,
adequate oral pain relief and mobile. They will receive
a total course of 10 days of antibiotics (intravenous and
oral) following randomisation.
Children within the non-operative treatment group will
remain under the direct care of an attending paediatric
surgeon. If a child’s clinical condition deteriorates at any
time, they will undergo laparoscopic appendectomy, and
will receive postoperative care identical to that of children in the appendectomy treatment group (see below),
and any other care that might be dictated by sound clinical judgement.
4

The diagnosis of acute appendicitis may be confirmed,
or strongly suspected in an otherwise eligible patient at
an outside institution, prior to referral to the treating/
trial centre. A widely accepted standard of practice made
in consultation with the treating centre, is to administer a
single dose of intravenous antibiotic in such patients prior
to transfer. These patients will be considered eligible for
randomisation provided they have not received more
than a single dose of pretransfer intravenous antibiotic.
A patient who has received two or more doses of antibiotic prior to evaluation at the treating/trial centre will be
considered to have ‘commenced conservative treatment’,
and would therefore be ineligible for randomisation. The
choice of antibiotics will vary between centres and will be
the antibiotic regimen that is current standard of care in
that centre. This is due to (1) varying antibiotic regimes
Hall NJ, et al. BMJ Paediatrics Open 2017;1:e000028. doi:10.1136/bmjpo-2017-000028
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Figure 1 Clinical flow chart for APPY trial.
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Appendectomy group
Children allocated to appendectomy will undergo laparoscopic appendectomy within approximately 18 hours
of randomisation which is the current standard of care
in all centres participating in this study. Participants will
receive intravenous antibiotics from the time of randomisation and be treated postoperatively with intravenous
antibiotics according to a defined and standardised treatment regime based on consensus for this trial. Specifically,
children with a macroscopically normal appendix or
non-perforated acute appendicitis will receive no further
antibiotics; children with perforated appendicitis will
continue to receive intravenous antibiotics for a minimum
of 3 days, and may receive additional antibiotics per local
practice. The type of antibiotics used in each centre will
be identical to those used in the non-operative treatment
group. Following cessation of intravenous antibiotics,
criteria for discharge home will be identical to those in
the non-operative treatment group.
Outcomes
Primary outcome
The primary outcome is treatment failure defined as: (1)
additional intervention related to appendicitis requiring
general anaesthesia within 1 year of randomisation (this
includes the recurrence of appendicitis after non-operative treatment, which will be treated with appendectomy)
or (2) negative appendectomy. This definition of the
primary outcome will capture all important parameters in both treatment groups including specifically:
failure of antibiotic treatment requiring appendectomy,
significant complication (defined as requiring general
anaesthesia) in either treatment group, recurrence of
acute appendicitis (treated by appendectomy) and negative appendectomy.
Secondary outcomes
Secondary outcomes are objective measures of treatment
efficacy that fulfil important core areas of relevance to
clinicians and patients (pathophysiological manifestations, life impact, resource use and death).21 We have
Hall NJ, et al. BMJ Paediatrics Open 2017;1:e000028. doi:10.1136/bmjpo-2017-000028

selected secondary outcomes which we believe to be
important and relevant for future treatment decisions.
They will be recorded as they illustrate clinical course and
are objectively measurable in a large multicentre RCT:
►► complications: adverse events related to either nonoperative treatment of appendicitis or appendectomy
which require additional interventions without
general anaesthesia, during the first year following
randomisation will be categorised according to the
Clavien-Dindo classification22
►► time to discharge home after randomisation
measured in hours as a continuous variable
►► number and duration of hospital admissions
related to appendicitis, appendectomy or their
complications during the first year following
randomisation
Other secondary outcomes will be collected and
compared between treatment groups. We will also undertake a full cost-effectiveness analysis to examine the
incremental cost (savings) of non-operative treatment
versus appendectomy per treatment failure averted.
Follow-up
All participants will be seen in the outpatient clinic at
6 weeks following discharge and again at 3 months and
1 year following randomisation for collection of secondary
outcome data. Details of any unscheduled healthcare
visits specific to the previous episode of appendicitis will
be recorded contemporaneously if at the same institution, or will be inquired about at the 3-month and 1-year
follow-up appointments. If families are unable to attend
for follow-up then consultation by telemedicine facility or
telephone will be undertaken.
We will obtain permission from these families to hold
their personal contact details in a secure registry and
to contact them in the future to determine in a longer
follow-up study if they have had complications that may
be attributed to treatment (including recurrence of
appendicitis).
Sample size calculation
The sample size has been calculated to test our null
hypothesis that non-operative treatment with antibiotics
is inferior to appendectomy. Data contributing to our
calculations arise from our pilot RCT data,16 the existing
literature in adult patients and recent (2012) outcomes
data from the 14 participating centres.
In the appendectomy treatment group, the estimate of participants meeting criteria for the primary end point is based
on the negative appendectomy rate and postoperative
need for re-intervention rate, which were estimated from
the recent experience collected from each participating
centre. We found a 5% negative appendectomy rate and
2% postappendectomy rate of intervention requiring
general anaesthesia. The anticipated proportion of
participants with treatment failure in the appendectomy
group is therefore 7%.
5
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among participating centres at present influenced by
local factors, including antimicrobial stewardship and
drug cost20 and (2) a lack of evidence to support a specific
antibiotic regimen for childhood appendicitis. Allowing
each centre to maintain current antibiotic protocols will
improve study feasibility and increase generalisability of
the results. However, the duration of combined intravenous and oral therapy will be standardised to 10 days.
Following discharge, children who receive non-operative treatment will not be offered elective appendectomy.
They will be counselled about the risk of recurrence as
part of the consent process for the trial using best available data including that arising from our pilot study.
Recurrence of appendicitis within the 1-year follow-up
period will be treated with appendectomy; these children
will not be eligible for re-enrolment.

Open Access

Analysis
Final analysis will be performed after the final patient has
completed 1 year follow-up after randomization. Baseline
variables will be compared between groups using the
appropriate descriptive statistics. The primary outcome
will be analysed by testing, at the 5% level (one-sided),
the null hypotheses H0:µnon-op - µop>0.2 (inferiority) versus
the alternative hypothesis HA1:µnon-op - µop≤0.13 (non-inferiority), where µnon-op and µop are the probabilities of
the primary outcome occurring in the non-operative
arm and the operative arm, respectively. To facilitate
this test of hypothesis, the 90% CI for µnon-op - µop will be
constructed. If the upper-bound of the CI is less than 0.2,
the null hypothesis will be rejected and the non-operative arm will be declared non-inferior. Time to discharge
will be compared between treatment arms using a MannWhitney U-test to account for right skewing from most
patients spending a short time in the hospital with few
and widely variable protracted stays. The incidence of
complications will be compared between treatment
arms using a two-sided Fisher exact test. The number of
hospital admissions will be compared between treatment
arms using a Poisson model and the total duration of
hospital admissions in the first year following randomization will be compared between treatment arms using a
Mann-Whitney U-test. All outcomes will be analysed on
an intention-to-treat basis. We will also analyse outcomes
by the stratification criteria (gender, duration of symptoms, centre). As an exploratory analysis in the subset
of patients for whom the presence/absence of faecolith
is known, an analysis of the primary outcome similar to
the one described above will be performed with the presence/absence of appendicolith as a covariate.
To ascertain the efficacy of treatment in the non-operative treatment groups, we will perform an interim
analysis for the first half of the planned sample size.
6

It will not be possible to use the primary outcome as
defined for this interim analysis as data contributing
to the primary outcome will not become measurable
until 1 year following randomisation. With a planned
1 year recruitment period to recruit ~50% of patients
and with a 1 year follow-up, the time point at which this
interim analysis would be performed would unavoidably occur near the end of our planned recruitment
period (ie,~24 months). We will therefore perform an
interim analysis based on a modified primary outcome
with a shorter (3 month following randomization)
follow-up period. This analysis will be based on all
elements of the primary outcome but with shorter
follow-up. At the interim analysis we will test at the 0.01
level (one-sided) the hypothesis HI0: µnon-op - µop≤0.13
(non-inferiority) versus the alternative hypothesis HI1:
µnon-op - µop>0.13 (inferiority), where µnon-op and µop are
the probabilities of the 3 month primary end point
occurring in the non-operative arm and the operative
arm, respectively. If the hypothesis HI0 is rejected in
favour of HI1, patient recruitment will be stopped and
the non-operative arm declared inferior. No adjustment for the final analysis will be required since the
interim and final analyses test different hypotheses.
The interim analysis will be performed blind to the
investigators to minimise the effect of bias influencing
subsequent patient treatment.
The objective of the economic evaluation is to measure
the incremental costs of non-operative management
versus surgical treatment for acute non-perforated
appendicitis per treatment failure averted from societal
and healthcare system perspectives. The design will be a
cost-effectiveness analysis that weighs the direct and indirect healthcare costs in both treatment arms against the
primary measure of effectiveness—treatment failures.
The study will capture all costs and health consequences
over a 1-year period following randomisation. Variables
listed as secondary outcomes in the proposal (frequency
and duration of hospital admissions, surgical interventions, treatment for adverse events and complications)
will be included as cost items in the analysis. These analyses will be country-specific to reflect pricing differences.
Only direct and indirect costs and resource use that can
be attributed to the management of acute appendicitis
and related complications will be included. Costs will be
aggregated into major categories (intervention, direct
healthcare, direct and indirect patient costs), and the
mean cost per child will be calculated for each treatment
group.
The effect of uncertainty will be tested through
extensive sensitivity analysis. Uncertain parameters may
include the rate of treatment failures, hospital admission length of stay and cost, and the unit price for costly
procedures. The probabilistic sensitivity analysis will
also be used to undertake a net monetary benefit calculation.
Hall NJ, et al. BMJ Paediatrics Open 2017;1:e000028. doi:10.1136/bmjpo-2017-000028
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In the non-operative treatment group the estimate of participants meeting criteria for the primary end point is based
on a 20% incidence of additional intervention requiring
general anaesthesia related to appendicitis (combination of treatment failure, complication requiring general
anaesthesia or recurrent appendicitis)
We will set a non-inferiority margin of 20% for this
study. Thus the primary null hypothesis for this trial is
H0:µnon-op - µop>0.2 (inferiority), where µnon-op and µop are
the probabilities of the primary outcome occurring in the
non-operative arm and the appendectomy arm, respectively. The alternative hypothesis on which the sample
size is based on is H1:µnon-op - µop≤0.13 (ie, 20%–7%). The
power for this trial will be set to 90%; therefore to have a
90% probability of rejecting H0 when H1 is true, using a
one-sided, 0.05 level test, we will require a total of 880 children (two equal groups of 440). To allow for a combined
10% drop out and loss to follow-up, we intend to recruit
978 (ie, 880/0.9) children in total. Based on the characteristics of participating centres we estimate recruitment
will take place over a period of 24–30 months.

Open Access

Ethical considerations
This study will be conducted in accordance with the principles of the Declaration of Helsinki and ‘good clinical
practice’ guidelines as defined by each trial site. Written
informed consent will be obtained from all participants
prior to randomisation. Our pilot RCT and ongoing
observational cohort studies suggest that non-operative
treatment of uncomplicated appendicitis in children is
safe.16 26 27

DISCUSSION
The APPY trial is based on the hypothesis that a high
proportion of children with acute uncomplicated appendicitis can be successfully treated with broad-spectrum
antibiotics thereby avoiding a large number of appendectomies. Previous studies of the use of antibiotics in
both adults and children suggest that this is likely to be
achievable. Whether non-operative treatment with antibiotics is as effective a treatment as appendectomy for this
patient population, however, is a more complex question.
We believe this is determined by other factors in addition to the success of the initial treatment. For this reason
these parameters are included in our composite primary
outcome and include incidence of complications in each
group, incidence of negative appendectomy and recurrence of appendicitis.
The selection of an appropriate and relevant primary
outcome is important for any RCT. Selection of a primary
end point which does not reflect the interests of the stakeholder groups involved in treatment selection for a given
pathology is likely to lessen the relevance and impact of
a trial. For this reason it has been proposed that core
outcome sets (COS) be developed. A COS is an established set of outcomes to be measured when evaluating
treatment efficacy for a given condition and is usually
arrived at by consensus among multiple stakeholder
Hall NJ, et al. BMJ Paediatrics Open 2017;1:e000028. doi:10.1136/bmjpo-2017-000028

groups (eg, clinicians, researchers, patients/parents,
treatment commissioners). The adoption of a COS will
likely ensure that outcomes reported are relevant and of
importance to multiple stakeholder groups. Further, use
of a COS will ensure that a standardised set of outcome
measures is reported as a minimum for a given pathology
thereby minimising the heterogeneity in outcome
reporting between studies. This will improve comparability between studies in quantitative data synthesis
such as meta-analysis. Although efforts are underway to
develop a COS for children with acute appendicitis,28 a
COS does not exist at present.
We have therefore selected a primary end point that
we believe reflects the important aspects of treatment
outcomes on which we as clinicians and researchers
would base future treatment decisions for children with
acute appendicitis. We have also been influenced by our
discussions with our patients and their parents. Negative appendectomy is a frequent finding in most series
of paediatric appendectomy and suggests that an unnecessary operation has been performed. A benefit of a
non-operative approach would be to avoid an unnecessary operation, although at the cost of an unnecessary
course of antibiotics. Complications of treatment are
important when evaluating treatment efficacy. Our definition of complications has been designed to capture the
failure of non-operative treatment as well as complications requiring general anaesthesia in either treatment
group. General anaesthesia has been selected as a marker
of the impact of the complication on the patient as per
the widely used Clavien-Dindo classification of surgical
complications.22 Finally we have included recurrent
appendicitis in our primary outcome. If the rate of
recurrent appendicitis is high then the benefit of initial
non-operative treatment is less. If an appendectomy is
going to be required for recurrence then it may as well be
performed at first presentation. As the primary motivation of non-operative treatment is to avoid an operation
and general anaesthesia, we felt the components of
the primary outcome should reflect this motivation
and therefore be centred around general anaesthesia.
Other complications not requiring a general anaesthetic
are extremely important to capture and are therefore
included as a specific secondary outcome measure (ie,
complications not resulting in general anaesthesia classified according to the Clavien-Dindo Scale). In addition
the resource utilisation aspect of these complications will
be captured in the economic analysis.
Currently diagnosis of acute appendicitis in participating centres results in a false positive rate of 4%–6%,
that is, a 4%–6% rate of negative appendectomy. Thus,
some of those recovering from non-operative management of suspected acute appendicitis will likely be those
false positives who did not have acute appendicitis in the
first place, in addition to children with antibiotic-responsive acute appendicitis. As no pathological specimen is
taken from those who recover effectively with non-operative treatment, we will not accurately know how many
7
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Trial oversight and safety monitoring
A Trial Steering Committee (TSC) will be convened to ensure
that the trial is conducted to rigorous scientific, clinical
and ethical standards. A Data Safety and Monitoring
Committee (DSMC) will be convened that is independent of both the trial management group and those
providing therapy. Terms of reference and a charter will
be developed, based on the DAMOCLES (DAta Monitoring Committees: Lessons, Ethics, Statistics) Study
Group23 and StaR Child health Standard for Research
with Children,24 25 and agreed at an initial meeting at
the beginning of the trial prior to the onset of recruitment. Adverse events will be continuously monitored
within each centre and reported to the trial coordinating
centre. If any serious or unexpected adverse event occurs
it will be reported to the chair of the DSMC chair within
72 hours. A summary of adverse events will be reviewed at
interim analysis and the DSMC will make a recommendation to the TSC regarding continuation of the trial on
safety grounds.
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studies to optimise antibiotic therapy. However, the trial is
not powered to examine differences in antibiotic regimens
and as a result of this, comparison of antibiotic regimens
is not listed as a specific secondary end point. All centres
will use a broad-spectrum approach to overcome the limitations of a narrow-spectrum antibiotic regime encountered
by others8 29
We have specifically designed the APPY trial as an
RCT. We believe the RCT design is the most appropriate
methodology to determine the comparative effectiveness
of non-operative treatment compared with appendectomy.30 We are aware of the use of a ‘parent/patient
choice’ design used by other studies in both adults31
and children.32 Although parental choice may ultimately
prove to be important in the treatment of acute appendicitis in children, we believe this parental choice must be
informed by high quality evidence of the treatment failure
rates of each approach in identical groups of patients.
A parent preference design runs the risk of introducing
bias between the treatment arms, indeed such a bias is
almost implicit in the act of choice itself. Despite the challenges and limitations of an RCT, we therefore strongly
believe that a randomised study introduces less bias and
is superior to a parent preference-based study. The 40%
recruitment rate from the pilot RCT suggests that many
children and parents are uncomfortable with the possibility of not having the appendix removed, and while we
believe that even if the current large-scale trial indicates
non-inferiority of non-operative management, there will
likely always be some children and their parents who will
opt to have an operation. The recruitment rate from the
current trial will also be an important metric to gauge
potential generalisability on a wider scale.
An additional challenge for many surgical trials in
particular is to ensure generalisability of trial findings
after completion. This trial will therefore be a pragmatic
trial in which we will aim to use existing treatment pathways in use at participating centres yet with adequate
standardisation across treatment groups to allow meaningful comparison. Our entry criteria will therefore be
based on a clinical and/or radiological diagnosis of
acute, uncomplicated (non-perforated) appendicitis.
There will be no strict requirement for the diagnosis
to be based on US or CT scan. The patients who will be
eligible for recruitment to this trial are the very ones who
are currently being treated with appendectomy for acute
appendicitis no matter how the diagnosis is currently
made. Children with a faecolith on imaging or raised
white cell count or C-reactive protein will all be eligible
for inclusion. Finally the laparoscopic approach will be
the standard for children in the appendectomy arm since
this is the approach in current standard use at participating institutions.
Author affiliations
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of these patients actually had appendicitis. It would not
be ethically acceptable to undertake additional tests (eg,
CT, laparoscopic biopsy) in order to determine whether
these patients actually had appendicitis or not, but we
believe that not operating on patients who do not have
acute appendicitis is one of the potential benefits of
non-operative management.
An additional challenge is how to define efficacy in an
RCT such as this. We have selected a non-inferiority design
since we wish to evaluate whether non-operative treatment
is as effective, but not necessarily more effective, than the
current standard of care (appendectomy). If non-operative
treatment is as effective as appendectomy, the potential
benefits include avoiding surgery and its inherent risks,
avoiding general anaesthesia, a potential shorter recovery
time, and reduced costs to the institution and the healthcare system. Similar trials in adults have used comparative
designs. To determine the efficacy of non-operative treatment we will compare how inferior it is to appendectomy.
The non-inferiority margin we are willing to accept will in
part determine its efficacy.
There is no accepted guidance regarding the magnitude
of a non-inferiority margin for surgical trials. A previous
similar study in adults8 comparing surgery with non-operative treatment for acute appendicitis in adults used a
non-inferiority margin of 10%, which has been criticised by
some as being too narrow.29 A Cochrane review of appendectomy versus antibiotic treatment for acute appendicitis3
proposed a non-inferiority margin of 20% on the basis that
non-operative treatment may be marginally less effective but
be more patient friendly, thereby justifying a wider non-inferiority margin. We believe that avoidance of an abdominal
operation and general anaesthesia provides enough benefit
to the patient to justify this wider non-inferiority margin
of 20%. A recently reported RCT in adults used a 24%
non-inferiority margin.9 It was felt by the trial investigators
that setting a non-inferiority margin of more than 20%
would be too wide, as negative appendectomy is included
in the appendectomy group so that a wider margin would
be too ‘generous’ to the non-operative group. In addition,
even if the treatment failure rate of non-operative treatment falls outside the non-inferiority limits, the trial will
usefully inform the discussion between surgeons, patients
and their parents, and non-operative treatment might still
be regarded as a viable treatment option, although with a
lower success rate.
In the protocol, each centre is allowed to maintain
current antibiotic protocols. This is in keeping with current
concepts of local antibiotic stewardship and the fact that no
single antibiotic regime for acute appendicitis is of proven
efficacy over another. It is not the aim of the study to determine an optimal antibiotic therapy for acute appendicitis,
but to effectively answer the question ‘Is non-operative
management of acute appendicitis in children, using current
local antibiotic policies, non-inferior to operative management’. It is possible that some individual regimens may be
more effective than others, and data from the trial might
be used as hypothesis-generating in order to design future
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